AD Rule, LD Cornell… - Nephron Physiology, 2011 - content.karger.com Nephrosclerosis can be defined by the presence of glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis on renal biopsy. Chronic kidney disease is identified clinically by a reduction in glomerular filtration rate (GFR) and has been characterized histologically ...
CP Bramlage, GA Müller, B Tampe… - Journal of …, 2011 - ncbi.nlm.nih.gov Background: Bone morphogenetic protein-5 (BMP-5) has been shown to be essential for nephrogenesis. Its role in adult kidney and in patients with hypertensive nephrosclerosis is still unknown. Methods: BMP-5 expression was evaluated by immunostaining and real-time ...
T Krummel, D Bazin, AL Faller… - Presse medicale (Paris, …, 2011 - ncbi.nlm.nih.gov Hypertensive nephrosclerosis is the leading cause of end stage renal disease (ESRD) in France, however, in prospective clinical trials of hypertension, ESRD accounts only for a small fraction of all events (incidence rate 0.2 to 0.4% by year). Hypertensive nephrosclerosis is ...
CL Bockmeyer, V Forstmeier, F Modde… - Nephrology Dialysis …, 2011 - ERA-EDTA Background. Hypertensive nephrosclerosis alone and in combination with other renal diseases is a leading cause of terminal renal insufficiency. Histologic lesions manifest as benign nephrosclerosis (bN) with arteriolar hyalinosis and later fibrosis. Procoagulant micromilieus have been ... Cited by 1 - Related articles - All 5 versions
G Wang, FM Lai, BC Kwan, KB Lai… - Kidney and Blood …, 2011 - content.karger.com ... with Hypertensive Nephrosclerosis... Introduction Hypertensive nephrosclerosis (HTN) is an important complication of systemic hypertension and a major cause of end-stage renal disease (ESRD) [1, 2] . However, the pathogenesis of HTN is not completely clarified. ... Related articles - All 3 versions